Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BL-8040 Safety and Stem Cell Mobilization in Healthy Volunteers
NCT02073019Phase 1Completed
- Sponsor
- BioLineRx Ltd.
- Start
- Aug 2014
- Primary completion
- Jul 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of motixafortide in hematopoietic stem cell mobilization (3 cohorts), sponsored by BioLineRx Ltd. Primary endpoint: Number of subjects with Adverse Events. Started Aug 2014; status: completed.
02
Drugs
motixafortide
03
Conditions
hematopoietic stem cell mobilization
Beyond the preview
Go deeper on NCT02073019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02073019.